<DOC>
	<DOCNO>NCT00855595</DOCNO>
	<brief_summary>Subjects moderate papulopustular rosacea treat either azelaic acid 15 % gel topically plus anti-inflammatory dose doxycyline ( 40mg ) daily metronidazole 1 % gel topically daily plus anti-inflammatory dose doxycycline ( 40mg ) total twelve week determine rapidity improvement , length time reach 25 % , 50 % 75 % clearing compare baseline .</brief_summary>
	<brief_title>Efficacy Topical Azelaic Acid 15 % Gel Plus Anti-inflammatory Dose Doxycycline Metronidazole Gel 1 % Plus Anti-inflammatory Dose Doxycycline Moderate Papulopustular Rosacea</brief_title>
	<detailed_description>The change inflammatory lesion count assess post-baseline visit analysis variance model ( ANOVA ) factor treatment center , include treatment-by-center interaction . Investigator 's Global Assessment ( IGA ) papulopustular rosacea ( static score ) : 0 - Clear ( Virtually rosacea ie , papules and/or pustule ; residual erythema ; mild moderate degree telangiectasia may present ) ; 1 - Minimal ( Rare papules and/or pustule ; residual mild erythema ; mild moderate degree telangiectasia may present ) ; 2 - Mild ( Few papule and/or pustule ; mild erythema ; mild moderate degree telangiectasia may present ) ; 3 - Mild moderate ( Distinct number papule and/or pustule ; mild moderate erythema ; mild moderate degree telangiectasia may present ) ; 4 - Moderate ( Pronounced number papule and/or pustule ; moderate erythema ; mild moderate degree telangiectasia may present ) ; 5 - Moderate severe ( Many papule and/or pustule , occasionally large inflamed lesion ; moderate erythema ; moderate degree telangiectasia may present ) ; 6 - Severe ( Numerous papule and/or pustule , occasionally confluent area inflame lesion ; moderate severe erythema ; moderate severe degree telangiectasia may present ) .</detailed_description>
	<mesh_term>Rosacea</mesh_term>
	<mesh_term>Doxycycline</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<mesh_term>Azelaic acid</mesh_term>
	<criteria>Moderate papulopustular rosacea ( IGA &gt; 4 ) minimum 10 50 inflammatory lesion persistent erythema without telangiectasia Sensitivity treatment use Coexisting condition would unfavorably influence course disease Pregnant lactate woman Severe rosacea</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Rosacea</keyword>
</DOC>